TheraFlu Cold and Flu acetaminophen, pheniramine maleate, phenylephrine hydrochloride ACESULFAME POTASSIUM ANHYDROUS CITRIC ACID FD&C RED NO. 40 FD&C BLUE NO. 1 MAGNESIUM STEARATE MALTODEXTRIN SILICON DIOXIDE SUCROSE SODIUM CITRATE, UNSPECIFIED FORM TRIBASIC CALCIUM PHOSPHATE ACETAMINOPHEN ACETAMINOPHEN PHENIRAMINE MALEATE PHENIRAMINE PHENYLEPHRINE HYDROCHLORIDE PHENYLEPHRINE

Loose white powder containing white, yellow, and gray-violet granules. May contain soft clumps. When one packet is dissolved in hot water, a cloudy solution forms which is pink-violet in color with a berry aroma.

Indications: Infectious/inflammatory illnesses - influenza, ARVI (“common cold”), accompanied by a high temperature, chills, and fever, headache, rhinitis and nasal congestion, sneezing, and muscle pain

: Oral. The content of a packet is dissolved in 1 glass of boiling hot water. Consumed in hot form. Sugar can be added to taste. A repeated dose may be taken every 4 hours (no more than 3 doses in 24 hours). TheraFlu® can be used at any time of day, but taking the preparation before going to sleep, for the night, has the best effect. If there is no relief of symptoms within 3 days after the preparation is first taken, a physician must be consulted

: Increased sensitivity to individual ingredients of the preparation, simultaneous use of tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, beta-adrenergic blockers; portal hypertension; alcoholism; diabetes mellitus, pregnancy, breast-feeding, children under 12 years of age. With caution: in marked coronary artery atherosclerosis, in arterial hypertension, narrow-angle glaucoma, severe liver or kidney diseases, prostatic hyperplasia, blood diseases, glucose-6-phosphate dehydrogenase deficiency, congenital hyperbilirubinemia (Gilbert, Dubin-Johnson, and Rotor syndromes), hyperthyroidism, pheochromocytoma, bronchial asthma.

Side effects: possible allergic reactions (skin rash, pruritus, hives, angioedema), hyperexcitability, sleep disorder, reduction in the speed of psychomotor reactions, drowsiness, dizziness, nausea, vomiting, stomach pain, palpitations, blood pressure increase, dry mouth, accommodative palsy, increase in intraocular pressure, urinary retention. During prolonged use in high doses - hepatotoxic action, changes in blood count; nephrotoxicity.

Pharmacotherapeutic group: analgesics and antipyretics, paracetamol in combination with other preparations (excluding psycholeptics). ATC code: NO2BE51 Pharmacological properties: Combination preparation, has an antipyretic, anti-inflammatory, anti-edematous, analgesic, and anti-allergic action.

Store out of the reach of children.

Storage conditions: At a temperature below 25°C. Store out of the reach of children.